Latest PROSPERA News
Aug 16, 2023
AUSTIN, Texas--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA (cfDNA) testing, today announced that it has received confirmation that its Prospera Lung donor-derived cfDNA (dd-cfDNA) transplant assessment test has met coverage requirements from the Centers for Medicare & Medicaid Services’ (CMS) Molecular Diagnostics Services Program (MolDX). The MolDX technology assessment program has determined that Prospera Lung will be covered under the existing Medicare
PROSPERA Frequently Asked Questions (FAQ)
When was PROSPERA founded?
PROSPERA was founded in 1993.
Where is PROSPERA's headquarters?
PROSPERA's headquarters is located at 8610 N New Braunfels Ave, San Antonio.
What is PROSPERA's latest funding round?
PROSPERA's latest funding round is Grant.
Who are the investors of PROSPERA?
Investors of PROSPERA include Social Solutions.